Author Correction: Comparison of the effects of empagliflozin and sotagliflozin on a zebrafish model of diabetic heart failure with reduced ejection fraction
Inho Kim, Hyun-Jai Cho, Soo Lim, Seung Hyeok Seok, Hae-Young Lee
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPancreatic function and diabetes · Diabetes Treatment and Management
Correction to: Experimental & Molecular Medicine 10.1038/s12276-023-01002-3, published online 01 June 2023
After the online publication of this article, the authors noticed an error in the Results section.
The correct statement of this article should have read as below.
In the original article, there was an error in Fig. 3d using a duplicate image of the same DMHF group as in a previous study conducted simultaneously with this study. There was no change in the morphology of DMHF in both the previous study and this study. However, this study explained the changes in morphology caused by the treatment of Empagliflozin and Sotagliflozin in the DMHF model based on previous research results. Therefore, the misuse of the image did not affect the results and scientific conclusions of the article. We would now like to replace Fig. 3d to provide a new, more representative Fig. 3 as follows:
The authors apologize for any inconvenience caused.
The original article has been corrected.